158 related articles for article (PubMed ID: 27260623)
1. [Vitreous metastasis of malignant cutaneous melanoma during treatment with ipilimumab].
Kellermann N; Maier M; Feucht N
Ophthalmologe; 2017 Feb; 114(2):163-166. PubMed ID: 27260623
[TBL] [Abstract][Full Text] [Related]
2. Metastatic cutaneous malignant melanoma of the vitreous and retina.
Best SJ; Taylor W; Allen JP
Aust N Z J Ophthalmol; 1990 Nov; 18(4):397-400. PubMed ID: 2076288
[TBL] [Abstract][Full Text] [Related]
3. BILATERAL METASTATIC CUTANEOUS MELANOMA TO RETINA AND VITREOUS AFTER IPILIMUMAB TREATED WITH PARS PLANA VITRECTOMY AND RADIOTHERAPY.
Kanavati S; Ottensmeier C; Foria V; Krishnan R
Retin Cases Brief Rep; 2018 Summer; 12(3):184-187. PubMed ID: 27828902
[TBL] [Abstract][Full Text] [Related]
4. Metastatic cutaneous melanoma to the vitreous cavity masquerading as intermediate uveitis.
Soheilian M; Mirbabai F; Shahsavari M; Parvin M; Manieei F
Eur J Ophthalmol; 2002; 12(4):324-7. PubMed ID: 12220005
[TBL] [Abstract][Full Text] [Related]
5. Suppression of melanoma-associated neoangiogenesis by bevacizumab.
Jaissle GB; Ulmer A; Henke-Fahle S; Fierlbeck G; Bartz-Schmidt KU; Szurman P
Arch Dermatol; 2008 Apr; 144(4):525-7. PubMed ID: 18427047
[TBL] [Abstract][Full Text] [Related]
6. Vitreous metastasis from cutaneous melanoma while on checkpoint inhibitors.
Catapano TM; Bansal R; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100050. PubMed ID: 38492668
[No Abstract] [Full Text] [Related]
7. Cutaneous malignant melanoma metastatic to the vitreous.
Prabhakaran VC; Font RL
Retina; 2007 Mar; 27(3):379-81. PubMed ID: 17460596
[TBL] [Abstract][Full Text] [Related]
8. Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.
Francis JH; Berry D; Abramson DH; Barker CA; Bergstrom C; Demirci H; Engelbert M; Grossniklaus H; Hubbard B; Iacob CE; Jaben K; Kurli M; Postow MA; Wolchok JD; Kim IK; Wells JR
Ophthalmology; 2020 Feb; 127(2):240-248. PubMed ID: 31708274
[TBL] [Abstract][Full Text] [Related]
9. Cytology of metastatic cutaneous melanoma to the vitreous and retina.
Spraul CW; Martin DF; Hagler WS; Grossniklaus HE
Retina; 1996; 16(4):328-32. PubMed ID: 8865394
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanoma metastatic to the vitreous cavity.
Gündüz K; Shields JA; Shields CL; Eagle RC
Ophthalmology; 1998 Apr; 105(4):600-5. PubMed ID: 9544631
[TBL] [Abstract][Full Text] [Related]
11. A case of cutaneous melanoma metastatic to the vitreous cavity: possible pathomechanism and review of the literature.
Jaissle GB; Szurman P; Rohrbach JM; Gelisken F; Bartz-Schmidt KU
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):733-40. PubMed ID: 17120001
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
Di Giacomo AM; Danielli R; Guidoboni M; Calabrò L; Carlucci D; Miracco C; Volterrani L; Mazzei MA; Biagioli M; Altomonte M; Maio M
Cancer Immunol Immunother; 2009 Aug; 58(8):1297-306. PubMed ID: 19139884
[TBL] [Abstract][Full Text] [Related]
13. [Ocular metastasis of cutaneous melanoma].
Galland F; Balansard B; Conrath J; Forzano O; Ridings B
J Fr Ophtalmol; 2004 Feb; 27(2):166-8. PubMed ID: 15029046
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignant melanoma metastatic to the vitreous.
Cole EL; Zakov ZN; Meisler DM; Tuthill RJ; McMahon JT
Arch Ophthalmol; 1986 Jan; 104(1):98-101. PubMed ID: 3942553
[TBL] [Abstract][Full Text] [Related]
15. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
Metz CH; Bornfeld N; Metz KA; Gök M
Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
[TBL] [Abstract][Full Text] [Related]
16. Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma.
Leone G; Nassisi M; Viola F
JAMA Ophthalmol; 2023 Dec; 141(12):e233540. PubMed ID: 38127080
[TBL] [Abstract][Full Text] [Related]
17. Intraocular metastasis from cutaneous malignant melanoma.
Eide N; Syrdalen P
Acta Ophthalmol (Copenh); 1990 Feb; 68(1):102-6. PubMed ID: 2336925
[TBL] [Abstract][Full Text] [Related]
18. Organizing pneumonia as a side effect of ipilimumab treatment of melanoma.
Barjaktarevic IZ; Qadir N; Suri A; Santamauro JT; Stover D
Chest; 2013 Mar; 143(3):858-861. PubMed ID: 23460165
[TBL] [Abstract][Full Text] [Related]
19. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.
Pintova S; Sidhu H; Friedlander PA; Holcombe RF
Melanoma Res; 2013 Dec; 23(6):498-501. PubMed ID: 24113862
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
Crosson JN; Laird PW; Debiec M; Bergstrom CS; Lawson DH; Yeh S
J Immunother; 2015; 38(2):80-4. PubMed ID: 25658618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
